The regulatory role of microRNAs in EMT and cancer A Zaravinos Journal of oncology 2015 (1), 865816, 2015 | 320 | 2015 |
MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer J Radojicic, A Zaravinos, T Vrekoussis, M Kafousi, DA Spandidos, ... Cell cycle 10 (3), 507-517, 2011 | 318 | 2011 |
EMT factors and metabolic pathways in cancer I Georgakopoulos-Soares, DV Chartoumpekis, V Kyriazopoulou, ... Frontiers in oncology 10, 499, 2020 | 281 | 2020 |
Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice DV Chartoumpekis, A Zaravinos, PG Ziros, RP Iskrenova, AI Psyrogiannis, ... PloS one 7 (4), e34872, 2012 | 267 | 2012 |
Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd. Nat Commun 7, 12846, 2016 | 259 | 2016 |
Current perspectives in cancer immunotherapy T Christofi, S Baritaki, L Falzone, M Libra, A Zaravinos Cancers 11 (10), 1472, 2019 | 195 | 2019 |
An updated overview of HPV-associated head and neck carcinomas A Zaravinos Oncotarget 5 (12), 3956, 2014 | 164 | 2014 |
Identification of common differentially expressed genes in urinary bladder cancer A Zaravinos, GI Lambrou, I Boulalas, D Delakas, DA Spandidos PloS one 6 (4), e18135, 2011 | 156 | 2011 |
Epithelial–mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics M Koutsaki, DA Spandidos, A Zaravinos Cancer letters 351 (2), 173-181, 2014 | 141 | 2014 |
Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients NFCC De Miranda, K Georgiou, L Chen, C Wu, Z Gao, A Zaravinos, ... Blood, The Journal of the American Society of Hematology 124 (16), 2544-2553, 2014 | 135 | 2014 |
First-trimester maternal plasma cell-free fetal DNA and preeclampsia S Sifakis, A Zaravinos, N Maiz, DA Spandidos, KH Nicolaides American journal of obstetrics and gynecology 201 (5), 472. e1-472. e7, 2009 | 131 | 2009 |
Molecular detection methods of human papillomavirus (HPV) A Zaravinos, IN Mammas, G Sourvinos, DA Spandidos The International journal of biological markers 24 (4), 215-222, 2009 | 124 | 2009 |
RNA editing in the forefront of epitranscriptomics and human health T Christofi, A Zaravinos Journal of translational medicine 17 (1), 319, 2019 | 116 | 2019 |
Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder … A Zaravinos, J Radojicic, GI Lambrou, D Volanis, D Delakas, ... The Journal of urology 188 (2), 615-623, 2012 | 109 | 2012 |
Yin yang 1 expression in human tumors A Zaravinos, DA Spandidos Cell cycle 9 (3), 512-522, 2010 | 108 | 2010 |
HPV-associated lung cancers: an international pooled analysis C Ragin, M Obikoya-Malomo, S Kim, Z Chen, R Flores-Obando, D Gibbs, ... Carcinogenesis 35 (6), 1267-1275, 2014 | 96 | 2014 |
Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction M Koutsaki, S Sifakis, A Zaravinos, D Koutroulakis, O Koukoura, ... Growth Hormone & IGF Research 21 (1), 31-36, 2011 | 96 | 2011 |
Prevalence of human papilloma virus and human herpes virus types 1–7 in human nasal polyposis A Zaravinos, J Bizakis, DA Spandidos Journal of medical virology 81 (9), 1613-1619, 2009 | 95 | 2009 |
Genomic instability, mutations and expression analysis of the tumour suppressor genes p14ARF, p15INK4b, p16INK4a and p53 in actinic keratosis P Kanellou, A Zaravinos, M Zioga, A Stratigos, S Baritaki, G Soufla, ... Cancer letters 264 (1), 145-161, 2008 | 94 | 2008 |
The expression and prognostic impact of immune cytolytic activity-related markers in human malignancies: a comprehensive meta-analysis C Roufas, D Chasiotis, A Makris, C Efstathiades, C Dimopoulos, ... Frontiers in oncology 8, 27, 2018 | 93 | 2018 |